BiondVax Announces Appointment of Amir Reichman as New CEO

Pharma Industry Veteran in Vaccines will Assume Role Full Time March 2, 2021, with Focus on Developing Product Pipeline in Infectious Diseases JERUSALEM, Jan. 21, 2021 -- (Healthcare Sales & Marketing Network) -- BiondVax Pharmaceuticals Ltd. (Nasdaq: ... Biopharmaceuticals, Personnel BiondVax Pharmaceuticals, influenza, vaccine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news